Statistics

Total Visits

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program83

Select a period of time:

Number of views in the range

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program33

Views

Views
May 20257
June 20252
July 202518
August 20250
September 20253
October 20252
November 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil8
Spain4
Hong Kong2
Argentina2
Colombia1
Germany1
Egypt1
United Kingdom1
Paraguay1
 

Top cities views

Views
Madrid3
Hong Kong2
Alcorta1
Bell Ville1
Cairo1
Capelinha1
Caxias1
Cerro Grande do Sul1
Florianópolis1
Gary1